VIGLIETTO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.764
AS - Asia 2.679
EU - Europa 1.472
SA - Sud America 523
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 54
OC - Oceania 9
Totale 10.683
Nazione #
US - Stati Uniti d'America 5.592
SG - Singapore 1.231
CN - Cina 698
IT - Italia 696
BR - Brasile 401
IN - India 255
VN - Vietnam 244
DE - Germania 188
GB - Regno Unito 171
SE - Svezia 130
CA - Canada 107
FI - Finlandia 92
HK - Hong Kong 65
AR - Argentina 45
NL - Olanda 40
BD - Bangladesh 32
CZ - Repubblica Ceca 25
MX - Messico 24
EC - Ecuador 23
IQ - Iraq 22
ID - Indonesia 19
CO - Colombia 18
PL - Polonia 17
JP - Giappone 16
RU - Federazione Russa 15
FR - Francia 14
UA - Ucraina 14
UZ - Uzbekistan 14
CL - Cile 12
ES - Italia 12
TR - Turchia 12
LT - Lituania 11
PK - Pakistan 11
ZA - Sudafrica 11
AT - Austria 10
PY - Paraguay 9
CR - Costa Rica 8
IE - Irlanda 8
KE - Kenya 7
IR - Iran 6
SA - Arabia Saudita 6
SC - Seychelles 6
UY - Uruguay 6
VE - Venezuela 6
AU - Australia 5
DZ - Algeria 5
EG - Egitto 5
HN - Honduras 5
JM - Giamaica 5
JO - Giordania 5
NP - Nepal 5
YE - Yemen 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
MA - Marocco 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BB - Barbados 3
BY - Bielorussia 3
ET - Etiopia 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TN - Tunisia 3
BO - Bolivia 2
BS - Bahamas 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
KR - Corea 2
LB - Libano 2
NG - Nigeria 2
NO - Norvegia 2
PW - Palau 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BM - Bermuda 1
BZ - Belize 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
Totale 10.489
Città #
San Jose 936
Dallas 823
Ashburn 517
Chandler 480
Singapore 373
Santa Clara 237
Council Bluffs 217
Bengaluru 189
Hefei 187
Milan 170
Princeton 146
Munich 143
Chicago 141
Lawrence 141
London 124
Ho Chi Minh City 90
Wilmington 89
Beijing 85
Los Angeles 72
Boardman 69
Turku 66
Catanzaro 62
Hong Kong 62
Ottawa 56
Phoenix 50
Des Moines 46
New York 44
São Paulo 39
Hanoi 38
Rome 30
Olomouc 25
Shanghai 25
Helsinki 24
Naples 21
San Francisco 19
Brooklyn 18
Atlanta 16
Pune 16
Rio de Janeiro 15
The Dalles 15
Amsterdam 14
Chennai 14
Washington 14
Haiphong 13
Orem 13
Shenzhen 13
Tokyo 13
Boston 12
Columbus 12
Denver 12
Guangzhou 12
Tashkent 12
Aversa 11
Caserta 11
Dhaka 11
Warsaw 11
Mexico City 10
Montreal 10
Norwalk 10
Stockholm 10
Toronto 10
Bari 9
Guayaquil 9
Hanover 9
Houston 9
Manchester 9
New Delhi 9
Seattle 9
Taranto 9
Thái Bình 9
Assago 8
Aurora 8
Bologna 8
Buffalo 8
Da Nang 8
Frankfurt am Main 8
Johannesburg 8
Ninh Bình 8
Porto Alegre 8
Quito 8
Redmond 8
Baghdad 7
Charlotte 7
Mumbai 7
Padua 7
Palermo 7
San José 7
Caxias do Sul 6
Jinan 6
Lấp Vò 6
Maryland Heights 6
Osasco 6
Settingiano 6
Squillace 6
Trieste 6
Ann Arbor 5
Belo Horizonte 5
Biên Hòa 5
Bogotá 5
Erbil 5
Totale 6.448
Nome #
Hereditary Transthyretin Amyloidosis: Genetic Characterization of the TTR P.Val142Ile Variant in a Calabrian Kindred 194
Distinctive chromosomal, mutational and transcriptional profiling in colon versus rectal cancers 165
c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration 110
H Ferritin Gene Silencing in a Human Metastatic Melanoma Cell Line: A Proteomic Analysis 108
Atrial myxomas arise from multipotent cardiac stem cells 97
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 95
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 92
Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis 91
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 89
Adult Multipotent Cardiac Progenitor-Derived Spheroids: A Reproducible Model of In Vitro Cardiomyocyte Commitment and Specification 86
Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair 86
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 85
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 85
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 84
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 84
Comprehensive genetic analysis of laryngeal leiomyosarcoma by next generation sequencing: a case report 84
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors 83
Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers. 81
T-cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes 81
A mutated p53 gene alters thyroid cell differentiation 80
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo 79
Circulating non-hematological cells during cardiopulmonary bypass: new findings in cardiac surgery procedures 79
Identification of copy number alterations in colon cancer from analysis of amplicon-based Next generation sequencing data 78
From spheroids to organoids: The next generation of model systems of human cardiac regeneration in a dish 77
A Mouse Model of Dilated Cardiomyopathy Produced by Isoproterenol Acute Exposure Followed by 5-Fluorouracil Administration 77
The genetics of non-syndromic primary ovarian insufficiency: A systematic review 76
An interview with Dr. Giuseppe Viglietto on his highly cited paper published in Cell Cycle 75
Mutant AKT1-E17K is oncogenic in lung epithelial cells. 75
An adenovirus carrying the rat protein tyrosine phosphatase η suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo 75
Design and characterization of glyceryl monooleate-nanostructures containing doxorubicin hydrochloride 75
Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis 74
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 73
AKT1E17K is oncogenic in mouse lung and cooperates with chemical carcinogens in inducing lung cancer 73
Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy 72
Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy 72
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells. 72
In Vitro Silencing of lncRNAs Using LNA GapmeRs 72
Negative transcriptional regulation of the human periostin gene by YingYang-1 transcription factor 71
Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects 70
Tailoring chemometric models on blood-derived cultures secretome to assess personalized cancer risk score 70
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 70
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 70
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 69
Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype 69
BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage. 69
Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling. 69
AKT1E17K is oncogenic in mouse lung and cooperates with chemical carcinogens in inducing lung cancer 68
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 68
Controllo del ciclo cellulare e sue alterazioni nei tumori 68
A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors 68
Allelic variant at-79 (C > T) in CDKN1B (p27(Kip1)) confers an increased risk of thyroid cancer and alters mRNA levels 67
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer 67
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 67
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 67
A new mechanism of BRAF activation in human thyroid papillary carcinomas 66
Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma 66
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 66
PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest 65
The genetics of non-syndromic primary ovarian insufficiency: A systematic review 65
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 64
Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer 64
Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer 64
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models 63
Loss of p27 expression through RAS -> BRAF -> MAP kinase-dependent pathway in human thyroid carcinomas 62
The non-coding RNA landscape of plasma cell dyscrasias 62
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 61
Identification of mesothelial cells in intraoperative blood salvage. 61
Editorial: New strategies to tackle chemoresistance in cancer 60
c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration (vol 10, 436, 2019) 60
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas 60
HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas 60
Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing 59
Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma 59
Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells 58
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 57
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 57
Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis 56
Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy 56
Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing. 56
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene. 56
Cascade Genetic Testing for Hereditary Cancer Predisposition: Characterization of Patients in a Catchment Area of Southern Italy 55
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins 55
Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase 55
MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer. 55
High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncology reports 11: 0-00, 2004 55
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas 55
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas 55
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 54
RET/PTC oncogene activation is an early event in thyroid carcinogenesis 54
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 54
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 53
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic 52
The placenta growth factor gene of the mouse 52
Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo 52
Thymosin beta-10 gene overexpression is a general event in human carcinogenesis 52
The Nonreceptor-Type Tyrosine Phosphatase PTPN13 Is a Tumor Suppressor Gene in Non-Small Cell Lung Cancer 52
Contribution of PKB/AKT signaling to thyroid cancer 51
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 51
The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib 51
Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas. 50
Totale 7.047
Categoria #
all - tutte 96.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022370 0 0 0 92 35 2 14 88 34 36 64 5
2022/20231.321 294 47 44 101 172 121 10 121 232 57 99 23
2023/2024749 160 88 51 59 46 177 31 9 0 17 42 69
2024/20252.000 277 146 89 77 130 241 33 75 251 81 228 372
2025/20264.885 279 510 967 618 444 187 576 298 466 375 115 50
2026/20271.107 88 249 514 256 0 0 0 0 0 0 0 0
Totale 10.683